Home
About
FAQ
History (8)
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.
Volumetric splenic injury measurement in ct scans for comparison with injury score.
Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Brain Strain: Computational Model-Based Metrics for Head Impact Exposure and Injury Correlation.
The pharmacoeconomics of acne treatment: where are we heading?
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The pharmacoeconomics of acne treatment: where are we heading?
Inglese MJ, Fleischer AB, Feldman SR, Balkrishnan R. The pharmacoeconomics of acne treatment: where are we heading? J Dermatolog Treat. 2008; 19(1):27-37.
View in:
PubMed
subject areas
Acne Vulgaris
Anti-Bacterial Agents
Cost-Benefit Analysis
Costs and Cost Analysis
Dermatologic Agents
Drug Administration Routes
Drug Resistance, Bacterial
Humans
Managed Care Programs
Models, Economic
authors with profiles
Steven R. Feldman MD, PhD